G M De Marchis1, M Katan2, C Barro1, J Fladt1, C Traenka1, D J Seiffge1, L Hert1, H Gensicke1, G Disanto3, R Sutter1,4, N Peters1, H Sarikaya5, B Goeggel-Simonetti5,6, M El-Koussy7, S Engelter1, P A Lyrer1, M Christ-Crain8, M Arnold5, J Kuhle1, L H Bonati1. 1. Department of Neurology and Stroke Center, University Hospital Basel, University of Basel, Basel. 2. Department of Neurology, University Hospital Zurich, Zurich. 3. Department of Neurology, Neurocenter of Southern Switzerland, Lugano. 4. Department of Intensive Care Medicine, University Hospital Basel, University of Basel, Basel. 5. Department of Neurology, Inselspital, Bern. 6. Department of Pediatrics, San Giovanni Hospital, Bellinzona. 7. Department of Neuroradiology, Inselspital, Bern. 8. Department of Internal Medicine and Department of Clinical Research, Division of Endocrinology, Diabetology and Metabolism, University Hospital Basel, University of Basel, Basel, Switzerland.
Abstract
BACKGROUND AND PURPOSE: Serum neurofilaments are markers of axonal injury. We addressed their diagnostic and prognostic role in acute ischemic stroke (AIS) and transient ischemic attack (TIA). METHODS: Nested within a prospective cohort study, we compared levels of serum neurofilament light chain (sNfL) drawn within 24 h from symptom onset in patients with AIS or TIA. Patients without magnetic resonance imaging on admission were excluded. We assessed whether sNfL was associated with: (i) clinical severity on admission, (ii) diagnosis of AIS vs. TIA, (iii) infarct size on admission magnetic resonance diffusion-weighted imaging (MR-DWI) and (iv) functional outcome at 3 months. RESULTS: We analyzed 504 patients with AIS and 111 patients with TIA. On admission, higher National Institutes of Health Stroke Scale (NIHSS) scores were associated with higher sNfL: NIHSS score < 7, 13.1 pg/mL [interquartile range (IQR), 5.3-27.8]; NIHSS score 7-15, 16.7 pg/mL (IQR, 7.4-34.9); and NIHSS score > 15, 21.0 pg/mL (IQR, 9.3-40.4) (P = 0.01). Compared with AIS, patients with TIA had lower sNfL levels [9.0 pg/mL (95% confidence interval, 4.0-19.0) vs. 16.0 pg/mL (95% confidence interval, 7.3-34.4), P < 0.001], also after adjusting for age and NIHSS score (P = 0.006). Among patients with AIS, infarct size on admission MR-DWI was not associated with sNfL, either in univariate analysis (P = 0.15) or after adjusting for age and NIHSS score on admission (P = 0.56). Functional outcome 3 months after stroke was not associated with sNfL after adjusting for established predictors. CONCLUSIONS: In conclusion, among patients admitted within 24 h of AIS or TIA onset, admission sNfL levels were associated with clinical severity on admission and TIA diagnosis, but not with infarct size on MR-DWI acquired on admission or functional outcome at 3 months.
BACKGROUND AND PURPOSE: Serum neurofilaments are markers of axonal injury. We addressed their diagnostic and prognostic role in acute ischemic stroke (AIS) and transient ischemic attack (TIA). METHODS: Nested within a prospective cohort study, we compared levels of serum neurofilament light chain (sNfL) drawn within 24 h from symptom onset in patients with AIS or TIA. Patients without magnetic resonance imaging on admission were excluded. We assessed whether sNfL was associated with: (i) clinical severity on admission, (ii) diagnosis of AIS vs. TIA, (iii) infarct size on admission magnetic resonance diffusion-weighted imaging (MR-DWI) and (iv) functional outcome at 3 months. RESULTS: We analyzed 504 patients with AIS and 111 patients with TIA. On admission, higher National Institutes of Health Stroke Scale (NIHSS) scores were associated with higher sNfL: NIHSS score < 7, 13.1 pg/mL [interquartile range (IQR), 5.3-27.8]; NIHSS score 7-15, 16.7 pg/mL (IQR, 7.4-34.9); and NIHSS score > 15, 21.0 pg/mL (IQR, 9.3-40.4) (P = 0.01). Compared with AIS, patients with TIA had lower sNfL levels [9.0 pg/mL (95% confidence interval, 4.0-19.0) vs. 16.0 pg/mL (95% confidence interval, 7.3-34.4), P < 0.001], also after adjusting for age and NIHSS score (P = 0.006). Among patients with AIS, infarct size on admission MR-DWI was not associated with sNfL, either in univariate analysis (P = 0.15) or after adjusting for age and NIHSS score on admission (P = 0.56). Functional outcome 3 months after stroke was not associated with sNfL after adjusting for established predictors. CONCLUSIONS: In conclusion, among patients admitted within 24 h of AIS or TIA onset, admission sNfL levels were associated with clinical severity on admission and TIA diagnosis, but not with infarct size on MR-DWI acquired on admission or functional outcome at 3 months.
Authors: Frederick K Korley; Jason Goldstick; Mitra Mastali; Jennifer E Van Eyk; William Barsan; William J Meurer; Jeremy Sussman; Hayley Falk; Deborah Levine Journal: Stroke Date: 2019-05-29 Impact factor: 7.914
Authors: Niklas Mattsson; Nicholas C Cullen; Ulf Andreasson; Henrik Zetterberg; Kaj Blennow Journal: JAMA Neurol Date: 2019-07-01 Impact factor: 18.302
Authors: Juha Onatsu; Ritva Vanninen; Pekka JÄkÄlÄ; Pirjo Mustonen; Kari Pulkki; Miika Korhonen; Marja Hedman; Kina HÖglund; Kaj Blennow; Henrik Zetterberg; Sanna-Kaisa Herukka; Mikko Taina Journal: In Vivo Date: 2020 Sep-Oct Impact factor: 2.155
Authors: Marion Moseby-Knappe; Niklas Mattsson; Niklas Nielsen; Henrik Zetterberg; Kaj Blennow; Josef Dankiewicz; Irina Dragancea; Hans Friberg; Gisela Lilja; Philip S Insel; Christian Rylander; Erik Westhall; Jesper Kjaergaard; Matt P Wise; Christian Hassager; Michael A Kuiper; Pascal Stammet; Michael C Jaeger Wanscher; Jørn Wetterslev; David Erlinge; Janneke Horn; Tommaso Pellis; Tobias Cronberg Journal: JAMA Neurol Date: 2019-01-01 Impact factor: 18.302